About gadoteridol
Macrocyclic gadolinium-based MRI contrast agent
Used for
- Enhances MRI images of the brain and spine
- Helps detect or assess abnormalities in other body tissues
Usual adult dose
Usually 0.1 mmol/kg intravenously for MRI; dose depends on the scan and may be repeated only when needed.
Usual dose in children
For children aged 2 years and older, usually 0.1 mmol/kg intravenously; safety is not established below age 2.
Common side effects
- Headache
- Nausea
- Dizziness
- Injection-site discomfort or warmth
Important warnings
- Rare severe allergic reactions can occur.
- Kidney impairment increases the risk of nephrogenic systemic fibrosis; assess kidney function when appropriate.
- Gadolinium may remain in the body after imaging; use only when clinically necessary.
- Use caution with asthma or a history of allergic reactions.
Pregnancy
Use during pregnancy only when the MRI contrast is clearly necessary; discuss potential risks with a clinician.
Breastfeeding
Breastfeeding generally does not need to be interrupted after administration; discuss concerns with a clinician.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.